Pain Management Devices Market Size to Hit USDD 13.06 Bn by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pain Management Devices Market

5.1. COVID-19 Landscape: Pain Management Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pain Management Devices Market, By Product

8.1. Pain Management Devices Market, by Product Type,

8.1.1. Electrical Stimulation Devices (TENS, Others)

8.1.1.1. Market Revenue and Forecast

8.1.2. Radiofrequency (RF) Ablation Devices

8.1.2.1. Market Revenue and Forecast

8.1.3. Neuromodulation Devices

8.1.3.1. Market Revenue and Forecast

8.1.4. Infusion Pumps (Intrathecal Infusion Pumps, External Infusion Pumps)

8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Pain Management Devices Market, By Application

9.1. Pain Management Devices Market, by Application

9.1.1. Musculoskeletal

9.1.1.1. Market Revenue and Forecast

9.1.2. Brain

9.1.2.1. Market Revenue and Forecast

9.1.3. Cancer

9.1.3.1. Market Revenue and Forecast

9.1.4. Neuropathy

9.1.4.1. Market Revenue and Forecast

9.1.5. Others

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Pain Management Devices Market, By End User

10.1. Pain Management Devices Market, by End User

10.1.1. Physiotherapy Centers

10.1.1.1. Market Revenue and Forecast

10.1.2. Hospitals and Clinics

10.1.2.1. Market Revenue and Forecast

10.1.3. Others

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Pain Management Devices Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End User

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End User

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End User

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End User

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End User

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End User

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End User

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End User

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End User

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End User

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End User

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End User

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End User

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End User

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End User

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End User

Chapter 12. Company Profiles

12.1. Nevro Corporation

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. LivaNova

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. SPR Therapeutics

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Boston Scientific Corporation

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Abbott

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. DJO Global LLC

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Medtronic

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Omron Healthcare Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Smiths Medical

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Melsungen AG

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence research, the global pain management devices market size is valued at USD 5.82 billion in 2025 and is predicted to reach USD 13.06 billion by 2034.

The global pain management devices market is expected to grow at a CAGR of 9.40% during the forecast period 2025 to 2034.

One of the important aspects likely to contribute to the growth of pain management devices market throughout the forecast period is an increase in the number of chronic disease cases. The rising frequency of diseases such as obesity and diabetes has boosted the demand for muscle and nerve stimulators, boosting the growth of pain management devices market.

The major players operating in the pain management devices market are Nevro Corporation, LivaNova, SPR Therapeutics, Boston Scientific Corporation, Abbott, DJO Global LLC, Medtronic, Omron Healthcare Inc., Smiths Medical, Melsungen AG.

North America is the largest segment for pain management devices market in terms of region. The expanding usage of pain management devices is likely to drive the growth of the North American pain management devices market during the forecast period.